Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Neel

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|September 6, 2012
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trialBen Tran, Andrew M K Brown, Philippe L Bedard, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
Cancer Discovery|May 16, 2012
Essential gene profiles in breast, pancreatic, and ovarian cancer cellsRichard Marcotte, Kevin R Brown, Fernando Suarez, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
The Journal of Clinical Investigation|February 18, 2025
Aberrant ERK signaling in astrocytes impairs learning and memory in RASopathy-associated BRAF mutant mouse modelsMinkyung Kang, Jihye Choi, Jeongho Han, et al.
Science Translational Medicine|April 29, 2021
SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populationsRomain Paccoud, Céline Saint-Laurent, Enzo Piccolo, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Human Mutation|July 16, 2015
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan SyndromeViviana Cordeddu, Jiani C Yin, Cecilia Gunnarsson, et al.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
Cancer Cell|February 25, 2024
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Ayushi S Patel, Eejung Kim, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|September 6, 2012
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trialBen Tran, Andrew M K Brown, Philippe L Bedard, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
Cancer Discovery|May 16, 2012
Essential gene profiles in breast, pancreatic, and ovarian cancer cellsRichard Marcotte, Kevin R Brown, Fernando Suarez, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
The Journal of Clinical Investigation|February 18, 2025
Aberrant ERK signaling in astrocytes impairs learning and memory in RASopathy-associated BRAF mutant mouse modelsMinkyung Kang, Jihye Choi, Jeongho Han, et al.
Science Translational Medicine|April 29, 2021
SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populationsRomain Paccoud, Céline Saint-Laurent, Enzo Piccolo, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Human Mutation|July 16, 2015
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan SyndromeViviana Cordeddu, Jiani C Yin, Cecilia Gunnarsson, et al.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
Cancer Cell|February 25, 2024
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Ayushi S Patel, Eejung Kim, et al.
Pageof 23